✦ LIBER ✦
NCIC CTG IND.122: a phase I/II pharmacokinetics (PK) and pharmacodynamic (PD) study of zd1839 (iressa ‘TM’). Final phase I results and preliminary phase II results of ZD1839 (750 mg/day) in patients (pts) with colorectal cancer
✍ Scribed by Goss, G.; Hirte, H.; Batist, G.; Miller, W.; Stewart, D.; Matthews, S.; Seymour, L.
- Book ID
- 122361815
- Publisher
- Elsevier Science
- Year
- 2001
- Tongue
- English
- Weight
- 182 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.